Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
中國生物製藥創新藥TQA3038完成I期臨床研究

2024-04-26T  
國藥附屬國藥一致首季淨利潤3.89億人民幣 增長7.3%

2024-04-26T  
四環醫藥三款門冬胰島素系列產品在專項接續採購中獲得擬中選資格

2024-04-25T  
《業績》山東新華製藥股份首季純利1.42億元人民幣跌6.4%

2024-04-25T  
副總理劉國中赴上海調研 稱推動醫學科技創新

2024-04-25T  
聯邦制藥阿莫西林克拉維酸鉀片獲藥監局通過一致性評價

2024-04-24T  
聯邦制藥胰島素產品擬中選國家藥品集中採購

2024-04-24T  
上海醫藥旗下新開發藥物獲國家藥監局受理

2024-04-22T  
下周備忘

2024-04-19T  
中國生物製藥創新藥羅伐昔替尼片關鍵註冊研究達主要終點

2024-04-19T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.